Article thumbnail

Matrin 3 is a co-factor for HIV-1 Rev in regulating post-transcriptional viral gene expression

By Venkat SRK Yedavalli and Kuan-Teh Jeang


Post-transcriptional regulation of HIV-1 gene expression is mediated by interactions between viral transcripts and viral/cellular proteins. For HIV-1, post-transcriptional nuclear control allows for the export of intron-containing RNAs which are normally retained in the nucleus. Specific signals on the viral RNAs, such as instability sequences (INS) and Rev responsive element (RRE), are binding sites for viral and cellular factors that serve to regulate RNA-export. The HIV-1 encoded viral Rev protein binds to the RRE found on unspliced and incompletely spliced viral RNAs. Binding by Rev directs the export of these RNAs from the nucleus to the cytoplasm. Previously, Rev co-factors have been found to include cellular factors such as CRM1, DDX3, PIMT and others. In this work, the nuclear matrix protein Matrin 3 is shown to bind Rev/RRE-containing viral RNA. This binding interaction stabilizes unspliced and partially spliced HIV-1 transcripts leading to increased cytoplasmic expression of these viral RNAs

Topics: Research
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2001). A Ran-independent pathway for export of spliced mRNA.
  2. (2003). A: Functional architecture of the nucleus: organizing the regulatory machinery for gene expression, replication and repair. Trends Cell Biol
  3. (2009). A: Transcriptional competence of the integrated HIV-1 provirus at the nuclear periphery.
  4. (2007). Beyond the sequence: cellular organization of genome function. Cell
  5. (2007). Bipartite nuclear localization signal of matrin 3 is essential for vertebrate cells. Biochem Biophys Res Commun
  6. (1994). BK: Elements distinct from human immunodeficiency virus type 1 splice sites are responsible for the Rev dependence of env mRNA.
  7. (2003). BK: PSF acts through the human immunodeficiency virus type 1 mRNA instability elements to regulate virus expression. Mol Cell Biol
  8. (2005). Blocking these effects prevents NMDA-induced neuronal death.
  9. (1989). BR: The HIV-1 rev transactivator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature
  10. (1991). CA: Identification and characterization of intragenic sequences which repress human immunodeficiency virus structural gene expression.
  11. (2008). CG: The PSF.p54nrb complex is a novel Mnk substrate that binds the mRNA for tumor necrosis factor alpha.
  12. (2009). Chanda SK: Host cell factors in HIV replication: meta-analysis of genome-wide studies. PLoS Pathog
  13. (2008). CL: Functions of the nuclear envelope and lamina in development and disease. Biochem Soc Trans
  14. (1993). Cloning and characterization of PSF, a novel pre-mRNA splicing factor. Genes Dev
  15. (1975). Coffey DS: Nuclear protein matrix: association with newly synthesized DNA. Science
  16. (1986). DS: The role of the nuclear matrix in the organization and function of DNA. Annu Rev Biophys Biophys Chem
  17. (2000). E: Binding of the Mex67p/Mtr2p heterodimer to FXFG, GLFG, and FG repeat nucleoporins is essential for nuclear mRNA export.
  18. (1997). E: CRM1 is responsible for intracellular transport mediated by the nuclear export signal. Nature
  19. (2003). et al: Nuclear microenvironments support physiological control of gene expression. Chromosome Res
  20. (1999). Felber BK: Identification of novel import and export signals of human TAP, the protein that binds to the constitutive transport element of the type D retrovirus mRNAs. Mol Cell Biol
  21. Felipo V: Activation of NMDA receptors induces protein kinase A-mediated phosphorylation and degradation of matrin
  22. (2007). Gene expression in nuclear microenvironments for biological control and cancer. Cancer Biol Ther
  23. (2005). GG: Retention and repression: fates of hyperedited RNAs in the nucleus. Curr Opin Cell Biol
  24. (2001). GG: The fate of dsRNA in the nucleus: a p54(nrb)-containing complex mediates the nuclear retention of promiscuously Ato-I edited RNAs. Cell
  25. (2005). GS: The dynamic organization of gene-regulatory machinery in nuclear microenvironments. EMBO Rep
  26. (2000). Half a century of “the nuclear matrix”. Mol Biol Cell
  27. (1994). Hammarskjold ML: A small element from the Mason-Pfizer monkey virus genome makes human immunodeficiency virus type 1 expression and replication Rev-independent. Proc Natl Acad Sci USA
  28. (1991). Identification of posttranscriptionally active inhibitory sequences in human immunodeficiency virus type 1 RNA: novel level of gene regulation.
  29. (2008). Identifying functional neighborhoods within the cell nucleus: proximity analysis of early S-phase replicating chromatin domains to sites of transcription,
  30. (2009). Inhibition of HIV-1 gene expression by Sam68 Delta C: multiple targets but a common mechanism? Retrovirology
  31. (2000). Izaurralde E: REF, an evolutionary conserved family of hnRNP-like proteins, interacts with TAP/Mex67p and participates in mRNA nuclear export. RNA
  32. (1997). Izaurralde E: The simian retrovirus-1 constitutive transport element, unlike the HIV-1 RRE, uses factors required for cellular mRNA export. Curr Biol
  33. (1997). JE: The constitutive transport element (CTE) of Mason-Pfizer monkey virus (MPMV) accesses a cellular mRNA export pathway.
  34. (2011). Jeang KT: Insights into Cellular Factors That Regulate HIV-1 Replication in Human Cells. Biochemistry
  35. (2006). Jeang KT: Replication of human immunodeficiency virus type 1 from entry to exit.
  36. (2011). Jeang KT: Rev-ing up post-transcriptional HIV-1 RNA expression.
  37. (1989). Jeang KT: Tat trans-activates the human immunodeficiency virus through a nascent RNA target. Cell
  38. (2006). Jeang KT: Transcriptional and post-transcriptional regulation of HIV-1 gene expression: role of cellular factors for Tat and Rev. Future Microbiol
  39. Jeang KT: Trimethylguanosine capping selectively promotes expression of Rev-dependent HIV-1 RNAs.
  40. (2004). Konarska MM: p54(nrb) associates with the 5’ splice site within large transcription/splicing complexes.
  41. (2009). Matrin 3: chromosomal distribution and protein interactions.
  42. (1997). Mattaj IW: CRM1 is an export receptor for leucine-rich nuclear export signals. Cell
  43. (2002). Matunis MJ: Proteomic analysis of the mammalian nuclear pore complex.
  44. (2011). Mechanisms employed by retroviruses to exploit host factors for translational control of a complicated proteome. Retrovirology 2009, 6:8. Yedavalli and Jeang Retrovirology
  45. (1991). Molecular cloning of matrin 3. A 125-kilodalton protein of the nuclear matrix contains an extensive acidic domain.
  46. (1989). MR: Sequence-specific RNA binding by the HIV-1 Rev protein. Nature
  47. (2008). Nuclear architecture and gene regulation. Biochim Biophys Acta
  48. (1998). Nuclear dreams: the malignant alteration of nuclear architecture.
  49. (2001). Nuclear envelope and nuclear matrix: interactions and dynamics. Cell Mol Life Sci
  50. (1991). Nuclear matrins: identification of the major nuclear matrix proteins.
  51. (2002). Nuclear matrix proteins as proteomic markers of preneoplastic and cancer lesions: commentary re: G. Brunagel et al., nuclear matrix protein alterations associated with colon cancer metastasis to the liver.
  52. (2002). Nuclear organisation and gene expression. Curr Opin Cell Biol
  53. (2004). Nuclear organization and the control of HIV-1 transcription. Gene
  54. (2001). Nuclear relocalization of the pre-mRNA splicing factor PSF during apoptosis involves hyperphosphorylation, masking of antigenic epitopes, and changes in protein interactions. Mol Biol Cell
  55. (1990). Pavlakis GN: Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1. J Virol
  56. (1992). Pavlakis GN: Distinct RNA sequences in the gag region of human immunodeficiency virus type 1 decrease RNA stability and inhibit expression in the absence of Rev protein.
  57. (1997). Pavlakis GN: Inactivation of the human immunodeficiency virus type 1 inhibitory elements allows Rev-independent expression of Gag and Gag/protease and particle formation.
  58. (1992). Pavlakis GN: Mutational inactivation of an inhibitory sequence in human immunodeficiency virus type 1 results in Rev-independent gag expression.
  59. (1989). Pavlakis GN: rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA. Proc Natl Acad Sci USA
  60. (2003). Recruitment of human cyclin T1 to nuclear bodies through direct interaction with the PML protein.
  61. (2002). Regulating the mammalian genome: the role of nuclear architecture. Adv Enzyme Regul
  62. (1998). Segregation of transcription and replication sites into higher order domains. Science
  63. (2006). Siliciano RF: Nuclear retention of multiply spliced
  64. (2008). SK: Nuclear microenvironments and cancer.
  65. (2007). T: Dynamic genome architecture in the nuclear space: regulation of gene expression in three dimensions. Nat Rev Genet
  66. (1990). TG: Mutational analysis of the human immunodeficiency virus type 1 Rev transactivator: essential residues near the amino terminus.
  67. (1997). The importin-beta family member Crm1p bridges the interaction between Rev and the nuclear pore complex during nuclear export. Curr Biol
  68. (1997). The nuclear matrix revealed by eluting chromatin from a cross-linked nucleu. Proc Natl Acad Sci USA
  69. (1988). The nucleoskeleton: artefact, passive framework or active site?
  70. (1998). The specificity of the CRM1-Rev nuclear export signal interaction is mediated by RanGTP.
  71. (2004). Vikmanis U: Role of the nuclear matrix proteins in malignant transformation and cancer diagnosis. Exp Oncol
  72. (2002). Zipori D: PSF and p54(nrb)/NonO–multi-functional nuclear proteins.